Back to Evidence
Primary experimental recordNegative / threshold

PMC12830260::ACT034433

TXM-CB3

Evidence text

Paper-level observation

Supp Fig. 2B and D: no significant differences were observed in the CA3 subfield.
textConfidence: medium

Assay observation

Activity
Antioxidant
Subtype
Not reported by source
Measure
other
Comparator
=
Raw observation
no significant differences A.U.
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple
Assay conditions
"original_unit=A.U."

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.